The duties of the Nomination Committee include the preparation and drafting of proposals regarding the election of members of the board of directors, the chairman of the board of directors, the chairman of the general meeting and auditors.
According to the instructions for Nomination Committee in Ascelia Pharma (publ), adopted at the annual general meeting held on 23 November 2018, the Nomination committee shall consist of four members representing the three largest shareholders per the end of March, together with the chairman of the board of directors. The three largest shareholders refer to the ownership group registered or in any other way known shareholders as per the end of March.
The nomination committee, for the 2019 Annual General Meeting, has the following composition:
- Jørgen Thorball, chairman of the Nomination Committee, appointed by Sunstone Life Science Ventures II K/S;
- Nils Lorentzen, appointed by CMC SPV of 3 April 2017 AB;
- Håkan Nelson, appointed by Øresund Healthcare Capital K/S; and
- Peter Benson, chairman of the board of directors.